Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
2005 1
2006 2
2007 1
2008 3
2009 2
2010 1
2011 2
2013 4
2014 5
2015 3
2016 3
2017 3
2018 3
2019 5
2020 1
2021 5
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system.
Enayatrad M, Mahdavi S, Aliyari R, Sahab-Negah S, Nili S, Fereidouni M, Mangolian Shahrbabaki P, Ansari-Moghaddam A, Heidarzadeh A, Shahraki-Sanavi F, Fateh M, Khajeha H, Emamian Z, Behmanesh E, Sheibani H, Abbaszadeh M, Jafari R, Valikhani M, Binesh E, Vahedi H, Chaman R, Sharifi H, Emamian MH. Enayatrad M, et al. BMC Infect Dis. 2023 Mar 10;23(1):150. doi: 10.1186/s12879-023-08103-4. BMC Infect Dis. 2023. PMID: 36899326 Free PMC article.
During the first week after the first dose of vaccines, the frequency of the pain for Sinopharm, AZD1222, Sputnik V, and Barekat was 35.5%, 86.0%, 77.6%, and 30.9%, respectively. ...In the first dose, it was 30.3% for Sinopharm, 67.4% for AZD1222, 47.6% for Sputnik V …
During the first week after the first dose of vaccines, the frequency of the pain for Sinopharm, AZD1222, Sputnik V, and Barekat was …
Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization.
Sheibani N, Wang S, Darjatmoko SR, Fisk DL, Shahi PK, Pattnaik BR, Sorenson CM, Bhowmick R, Volpert OV, Albert DM, Melgar-Asensio I, Henkin J. Sheibani N, et al. Exp Eye Res. 2019 Nov;188:107798. doi: 10.1016/j.exer.2019.107798. Epub 2019 Sep 11. Exp Eye Res. 2019. PMID: 31520600 Free PMC article.
Viability was unaffected in 3 retinal and 2 choroidal cell types by PEDF 335 up to 100 muM, PEDF 336 (100 muM) gave slight growth inhibition only in choroidal EC. A small anti-angiogenic PEDF epitope (G-Y-D-L-Y-R-V) was identified, variants (adipic-Sar-Y-N-L-Y-R-V) …
Viability was unaffected in 3 retinal and 2 choroidal cell types by PEDF 335 up to 100 muM, PEDF 336 (100 muM) gave slight growth inhibition …
Pre-Treatment with Erythropoietin Attenuates Bilateral Renal Ischemia-Induced Cognitive Impairments.
Tahamtan M, Sheibani V, Shid Moosavi SM, Asadi-Shekaari M, Esmaeili-Mahani S, Aghaei I, Shabani M. Tahamtan M, et al. Iran J Pharm Res. 2018 Spring;17(2):601-612. Iran J Pharm Res. 2018. PMID: 29881418 Free PMC article.
Eighty male Wistar rats were allocated into 8 groups: 1, 2) Sham +V (Vehicle), 3, 4) Sham+EPO, 5, 6) BRI+V, 7, 8) BRI+EPO. The groups followed by the reperfusion periods of 24hours (24 h) and 1week (1w). ...BUN (blood urea nitrogen) and creatinine (Cr) concentration …
Eighty male Wistar rats were allocated into 8 groups: 1, 2) Sham +V (Vehicle), 3, 4) Sham+EPO, 5, 6) BRI+V, 7, 8) BRI+EPO. The …
Synthesis and crystal structure of 2-amino-3-hydroxypyridinium dioxido(pyridine-2,6-dicarboxylato-kappa3O2,N,O6)vanadate(V) and its conversion to nanostructured V2O5.
Hejrani-Dalir A, Tabatabaee M, Sheibani A. Hejrani-Dalir A, et al. Acta Crystallogr C Struct Chem. 2015 Feb;71(Pt 2):89-92. doi: 10.1107/S2053229614027983. Epub 2015 Jan 12. Acta Crystallogr C Struct Chem. 2015. PMID: 25652272
2-Amino-3-hydroxypyridinium dioxido(pyridine-2,6-dicarboxylato-kappa(3)O(2),N,O(6))vanadate(V), (C5H7N2O)[V(C7H3NO4)O2] or [H(amino-3-OH-py)][VO2(dipic)], (I), was prepared by the reaction of VCl3 with dipicolinic acid (dipicH2) and 2-amino-3-hydroxypyridine (amino- …
2-Amino-3-hydroxypyridinium dioxido(pyridine-2,6-dicarboxylato-kappa(3)O(2),N,O(6))vanadate(V), (C5H7N2O)[V(C7H3NO4)O2] or [H( …
Chronic maternal morphine exposure and early-life adversity induce impairment in synaptic plasticity of adolescent male rats.
Fadaei-Kenarsary M, Esmaeilpour K, Shabani M, Sheibani V. Fadaei-Kenarsary M, et al. Neurosci Lett. 2023 Aug 24;812:137365. doi: 10.1016/j.neulet.2023.137365. Epub 2023 Jun 29. Neurosci Lett. 2023. PMID: 37393006
Therefore, this study aimed to evaluate the effects of chronic maternal morphine consumption (21 days before and after mating, and gestation), and MS (180 min/day from postnatal day (PND) 1-21) on the synaptic plasticity of male offspring in mid-adolescence. Control, MS, Vehicle …
Therefore, this study aimed to evaluate the effects of chronic maternal morphine consumption (21 days before and after mating, and gestation …
COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran.
Hosseinzadeh A, Sahab-Negah S, Nili S, Aliyari R, Goli S, Fereidouni M, Alami A, Shati M, Ahmadnezhad E, Mehravaran S, Fateh M, Khajeha H, Emamian Z, Behmanesh E, Mahdavi S, Enayatrad M, Mangolian Shahrbabaki P, Ansari-Moghaddam A, Heidarzadeh A, Shahraki-Sanavi F, Hashemi Shahri SM, Dehghan M, Amini Moridani M, Sheibani H, Abbaszadeh M, Jafari R, Valikhani M, Binesh E, Vahedi H, Chaman R, Khodashahi R, Amini M, Jabbari Azad F, Rezaeitalab F, Amel Jamehdar S, Eshraghi A, Sharifi H, Hashemi Bajgani SM, Mahdavi A, Jafarzadeh A, Farokhnia M, Ebrahimi S, Pardakhti A, Ghaderi E, Soltani H, Jadidoleslami S, Arianejad A, Gavili H, Moradveisi B, Motamedi D, Zare H, Kazemi T, Emamian MH. Hosseinzadeh A, et al. Bull World Health Organ. 2022 Aug 1;100(8):474-483. doi: 10.2471/BLT.22.288073. Epub 2022 Jun 22. Bull World Health Organ. 2022. PMID: 35923277 Free PMC article.
OBJECTIVE: To investigate the incidence of coronavirus disease 2019 (COVID-19) cases, hospitalizations and deaths in Iranians vaccinated with either AZD1222 Vaxzevria, CovIran vaccine, SARS-CoV-2 Vaccine (Vero Cell), Inactivated (lnCoV) or Sputnik V. METHODS: We enrolled i …
OBJECTIVE: To investigate the incidence of coronavirus disease 2019 (COVID-19) cases, hospitalizations and deaths in Iranians vaccinated wit …
48 results